Global Legalized Cannabis Market Overview:
Global Legalized Cannabis Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Legalized Cannabis Market Report 2026 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Legalized Cannabis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Legalized Cannabis Market:
The Legalized Cannabis Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Legalized Cannabis Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Legalized Cannabis Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Legalized Cannabis market has been segmented into:
Oils
Buds
Tinctures
By Application, Legalized Cannabis market has been segmented into:
Mental Disorders
Chronic Pain
Cancer
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Legalized Cannabis market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Legalized Cannabis market.
Top Key Players Covered in Legalized Cannabis market are:
Canopy Growth Corporation
GW Pharmaceuticals
plc
Aurora Cannabis Inc.
Aphria Inc.
Cronos Group
Tilray
Sundial Growers Inc.
Insys Therapeutics Inc.
The Scotts Company LLC
VIVO Cannabis Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Legalized Cannabis Market Type
4.1 Legalized Cannabis Market Snapshot and Growth Engine
4.2 Legalized Cannabis Market Overview
4.3 Oils
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Oils: Geographic Segmentation Analysis
4.4 Buds
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Buds: Geographic Segmentation Analysis
4.5 Tinctures
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Tinctures: Geographic Segmentation Analysis
Chapter 5: Legalized Cannabis Market Application
5.1 Legalized Cannabis Market Snapshot and Growth Engine
5.2 Legalized Cannabis Market Overview
5.3 Mental Disorders
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Mental Disorders: Geographic Segmentation Analysis
5.4 Chronic Pain
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Chronic Pain: Geographic Segmentation Analysis
5.5 Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Cancer: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Legalized Cannabis Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CANOPY GROWTH CORPORATION
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 GW PHARMACEUTICALS
6.4 PLC
6.5 AURORA CANNABIS
6.6 INC.
6.7 APHRIA
6.8 INC.
6.9 CRONOS GROUP
6.10 TILRAY
6.11 SUNDIAL GROWERS INC.
6.12 INSYS THERAPEUTICS
6.13 INC.
6.14 THE SCOTTS COMPANY LLC
6.15 VIVO CANNABIS INC.
Chapter 7: Global Legalized Cannabis Market By Region
7.1 Overview
7.2. North America Legalized Cannabis Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Oils
7.2.2.2 Buds
7.2.2.3 Tinctures
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Mental Disorders
7.2.3.2 Chronic Pain
7.2.3.3 Cancer
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Legalized Cannabis Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Oils
7.3.2.2 Buds
7.3.2.3 Tinctures
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Mental Disorders
7.3.3.2 Chronic Pain
7.3.3.3 Cancer
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Legalized Cannabis Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Oils
7.4.2.2 Buds
7.4.2.3 Tinctures
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Mental Disorders
7.4.3.2 Chronic Pain
7.4.3.3 Cancer
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Legalized Cannabis Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Oils
7.5.2.2 Buds
7.5.2.3 Tinctures
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Mental Disorders
7.5.3.2 Chronic Pain
7.5.3.3 Cancer
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Legalized Cannabis Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Oils
7.6.2.2 Buds
7.6.2.3 Tinctures
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Mental Disorders
7.6.3.2 Chronic Pain
7.6.3.3 Cancer
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Legalized Cannabis Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Oils
7.7.2.2 Buds
7.7.2.3 Tinctures
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Mental Disorders
7.7.3.2 Chronic Pain
7.7.3.3 Cancer
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Legalized Cannabis Scope:
|
Report Data
|
Legalized Cannabis Market
|
|
Legalized Cannabis Market Size in 2025
|
USD XX million
|
|
Legalized Cannabis CAGR 2025 - 2032
|
XX%
|
|
Legalized Cannabis Base Year
|
2024
|
|
Legalized Cannabis Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis Inc., Aphria Inc., Cronos Group, Tilray, Sundial Growers Inc., Insys Therapeutics Inc., The Scotts Company LLC, VIVO Cannabis Inc..
|
|
Key Segments
|
By Type
Oils
Buds
Tinctures
By Applications
Mental Disorders
Chronic Pain
Cancer
|
